Status:
COMPLETED
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Iron-deficiency
Hypersensitivity Reactions
Eligibility:
All Genders
16+ years
Brief Summary
This study aims to evaluate characteristics of patients with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer) including age,...
Eligibility Criteria
Inclusion
- Participants from 16 years of age and older with previous hypersensitivity reaction grades I-IV to intravenous ferric carboxymaltose (Ferinject) or to iron sucrose (Venofer).
Exclusion
- No previous hypersensitivity reaction to iron preparations or reactions to oral iron preparations.
- If a rejection to use patient data is documented in patient records, the patient will be excluded from analysis.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04359368
Start Date
September 1 2019
End Date
October 31 2019
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031